| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/06/1994 | EP0590689A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombinant technique |
| 04/06/1994 | EP0590309A2 Bone-related sulfatase-like protein and process for its production |
| 04/06/1994 | EP0590138A1 Oral treatment of helicobacter infection |
| 04/06/1994 | EP0590126A1 Polypeptides having kinase activity, their preparation and use |
| 04/06/1994 | EP0590109A1 $i(IN VIVO) BINDING PAIR PRETARGETING |
| 04/06/1994 | EP0590071A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-$g(b)1 BINDING MOLECULES AND USES THEREOF |
| 04/06/1994 | EP0590067A1 Microbially-produced antibody fragments and their conjugates |
| 04/06/1994 | EP0590058A1 Method for making humanized antibodies |
| 04/06/1994 | EP0590057A1 MIMIC PEPTIDES OF gp120 |
| 04/06/1994 | EP0590051A1 Intercellular adhesion molecule-3 and its binding ligands |
| 04/06/1994 | EP0590027A1 Insertional mutations in mycobacteria |
| 04/06/1994 | EP0589993A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 04/06/1994 | EP0589989A1 USE OF $g(b)-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 04/06/1994 | EP0589982A1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 04/06/1994 | EP0589951A1 Modified sialyl lewis?x compounds |
| 04/06/1994 | EP0589943A1 Mycobacterium proteins and applications |
| 04/06/1994 | EP0589875A1 Immune system stabilizers for prevention and therapy of disorders associated with immune system dysfunction |
| 04/06/1994 | EP0423195B1 Purified hematoporphyrin trimers useful in photodynamic therapy |
| 04/06/1994 | EP0353295B1 Novel and improved antibodies for site specific attachment of compounds |
| 04/06/1994 | EP0229126B1 Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors |
| 04/06/1994 | CN1084891A Sensory nerve antibody and preparing process |
| 04/06/1994 | CN1084855A PFEMP3 malaria antigen, analogs, antibodies and uses thereof |
| 04/06/1994 | CN1084743A High special transfer factor preparing process for B type hepatitis |
| 04/05/1994 | US5300632 Method for purifying an outer membrane protein of Haemophilus influenzae |
| 04/05/1994 | US5300631 Antibodies specific for either ras photo-oncogene encoded P21 proteins or ras oncogene encoded P21 proteins but not for both and method of producing same |
| 04/05/1994 | US5300278 Binding antibodies |
| 03/31/1994 | WO1994007143A1 Diagnosis of autosomal muscular dystrophy |
| 03/31/1994 | WO1994006921A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | WO1994006920A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/31/1994 | WO1994006912A1 Epstein-barr virus peptides and antibodies against these peptides |
| 03/31/1994 | WO1994006911A2 Mycoplasma pulmonis antigens and methods and compositions for use in cloning and vaccination |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006903A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | WO1994006830A1 Fibrinogen binding protein |
| 03/31/1994 | WO1994006828A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | WO1994006826A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006821A1 A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | WO1994006472A1 Antigen-carrying microparticles and their use in the induction of humoral or cellular responses |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006468A1 Recombinant influenza virus vaccine compositions |
| 03/31/1994 | WO1994006467A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 03/31/1994 | WO1994006466A1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection |
| 03/31/1994 | WO1994006465A1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| 03/31/1994 | WO1994006463A1 Immortalized cells and uses therefor |
| 03/31/1994 | WO1994006456A1 Protection against liver damage by hgf |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/31/1994 | WO1994006446A1 Hepatitis a virus vaccines |
| 03/31/1994 | WO1994006421A1 Recombinant multivalent m protein vaccine |
| 03/31/1994 | WO1994006345A2 Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof |
| 03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
| 03/31/1994 | WO1994003605A3 Compositions and methods for detecting human herpesvirus 6 strain z29 |
| 03/31/1994 | WO1994003589A3 Hepatitis a virus vaccine |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | CA2145063A1 Recombinant viruses displaying a nonviral polypeptide on their external surface |
| 03/31/1994 | CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144767A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 03/31/1994 | CA2144651A1 Immortalized cells and uses therefor |
| 03/31/1994 | CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | CA2144435A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 03/31/1994 | CA2144409A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | CA2142325A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | CA2124210A1 Fibrinogen binding protein |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589011A1 METHOD FOR THE DETERMINATION OF PLASMIN/$g(a)2-ANTIPLASMIN COMPLEXES AND THE USE OF THIS METHOD AS A MEAN OF DETERMINING CHANGES IN THE FIBRINOLYTIC SYSTEM |
| 03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/30/1994 | EP0588852A1 Immunosuppressive and tolerogenic oligosaccharide derivatives |
| 03/30/1994 | EP0588848A1 Modified sialyl lewis?a compounds |
| 03/30/1994 | EP0508993B1 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
| 03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/30/1994 | CN1084407A Method for producing clostridium perfringens vaccines |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298423 Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins |
| 03/29/1994 | US5298422 Myogenic vector systems |
| 03/29/1994 | US5298419 Diagnosis |
| 03/29/1994 | US5298416 Attenuated polioviruses |
| 03/29/1994 | US5298413 Attenuated polioviruses |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298393 Monoclonal antibody for human acid-glutathione S-transferase and process for preparation thereof |
| 03/29/1994 | US5298391 Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress |
| 03/29/1994 | US5298244 Proteins for immunology |
| 03/29/1994 | CA2106693A1 Immunoassay for isothiazolones |
| 03/29/1994 | CA1328071C Vaccine against pasteurella |
| 03/29/1994 | CA1328070C Purification process of bordetella bacteria protein antigens in order to obtain an acellular vaccine |